CANNAPHARMARX, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CANNAPHARMARX, INC. (CPMD) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- CANNAPHARMARX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.61M, a 428.21% increase from fiscal 2024.
- CANNAPHARMARX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $304.89K.
- CANNAPHARMARX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$2.17M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.61M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $304.89K 10-K · filed 2026-03-31 | $1.70M 10-K · filed 2025-04-10 |
| 2023-12-31 | -$2.17M 10-K · filed 2025-04-10 |